LeapZipBlog: Amanpreet's blog: Clinical Studies to Gain Significant Value by 2029

Clinical Studies to Gain Significant Value by 2029

November 11, 2019 by Amanpreet  

A latest report published by Fact.MR takes into account the eCOA, eSource & clinical trials market from a global as well as local viewpoint. The eCOA, eSource & clinical trials market is expected to grow at a CAGR of 14% over the forecast period 2019-2029.

In this Clinical studies, the following years are considered to project the market footprint:

  • History Year: 2014 - 2018
  • Base Year: 2014
  • Estimated Year: 2029
  • Forecast Year: 2019 – 2029

After reading the eCOA, eSource & clinical trials market report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the growth of the global eCOA, eSource & clinical trials market.
  • Analyze key regions holding significant share of the total eCOA, eSource & clinical trials market revenue.
  • Study the growth outlook of the global eCOA, eSource & clinical trials market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use on the eCOA, eSource & clinical trials market growth.
  • Investigate the recent R&D projects performed by each eCOA, eSource & clinical trials market player.

The eCOA, eSource & clinical trials market report covers the following regions:

  • North America (U.S., Canada)
  • Latin America (Argentina, Brazil)
  • Europe (Germany, France)
  • Middle East and Africa (Iran, Israel)
  • APEJ (China, India)

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4042

On the basis of product type, the eCOA, eSource & clinical trials market report considers the following segments:

  • ePROs (Patient Reported Outcomes)
  • ClinROs (Clinician Reported Outcomes)
  • ObsROs (Observer reported Outcomes)
  • PerfOs (Performance Outcomes)
  • Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS)
  • Randomization and Trial Supply Management Systems (RTMS)
  • Trail Planning and Safety Solutions
  • Electronic Data Capture (EDC)

On the basis of end-use, the eCOA, eSource & clinical trials market report includes:

  • Contract Research Organizations
  • Hospitals & Other Healthcare Facilities
  • Pharmaceutical/Biotechnology/Medical Devices Companies
  • Educational & Research Institutes

Prominent eCOA, eSource & clinical trials market players covered in the report contain:

  • PAREXEL International Corporation
  • Bio-Optronics, Inc.
  • Covance, Inc.
  • Medpace Holdings, Inc.
  • Medable
  • Medrio, Inc.
  • OmniComm Systems, Inc.
  • Health Diary, Inc.
  • ICON plc

The behavior pattern of each player – new product launches, partnerships, and acquisitions – has been analyzed in the eCOA, eSource & clinical trials market report comprehensively. In addition, the research encompasses the strengths, weaknesses, opportunities and threats of each eCOA, eSource & clinical trials market vendor in an in-depth manner.

The eCOA, eSource & clinical trials market report answers important questions which include:

  • What does the status of the eCOA, eSource & clinical trials market look like after the forecast period?
  • Which region has the highest contribution to the global eCOA, eSource & clinical trials market and why?
  • Which players remain at the top of the global eCOA, eSource & clinical trials market?
  • What opportunities are available for the eCOA, eSource & clinical trials market players to expand their production footprint?
  • Which segment has the maximum impact on the global eCOA, eSource & clinical trials market?

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=4042

Why Opt For Fact.MR?

  1. Various analysis methods to deliver precise market information.
  2. Digital technologies to facilitate clients with updated market solutions.
  3. Multi-disciplinary approach to provide accurate insights of different industries.
  4. Data collection from extensive primary and secondary research.
  5. Round-the-clock availability to serve clients across the world.